BioVaxys Technology Corp. (CSE:BIOV)
Canada · Delayed Price · Currency is CAD 0.2250
-0.0150 (-6.25%)
Jan 20, 2026, 3:59 PM EST
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 10.58 million as of January 20, 2026. Its market cap has decreased by -42.72% in one year.
Market Cap
10.58M
Enterprise Value
10.71M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 10.58M, a decrease of -60.89%. That is a compound annual growth rate of -16.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 10.58M | 9.09% |
| Dec 31, 2025 | 9.70M | -41.13% |
| Dec 31, 2024 | 16.48M | 127.10% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.15B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 2.02B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |